Miss Aline Wartanian
Karolinska University Hospital, Stockholm (Sweden)
DOAC versus warfarin in patients with atrial fibrillation and stage IV-V chronic kideny disease including patients on dialysis.
Event: ESC Congress 2021 - The Digital Experience
Topic: Oral Anticoagulation
Session: Atrial fibrillation e-posters
ESC 365 is supported by
